Massachusetts Financial Services
VIVO

Massachusetts Financial Services’s Meridian Bioscience Inc VIVO Stock Holding History

Massachusetts Financial Services’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,238
Closed -$266K – 901
2022
Q1 		$266K Sell
10,238
-95,949
-90% -$2.28M ﹤0.01% 849
2021
Q4 		$2.17M Sell
106,187
-18,051
-15% -$346K ﹤0.01% 770
2021
Q3 		$2.39M Sell
124,238
-1,630
-1% -$32.5K ﹤0.01% 767
2021
Q2 		$2.79M Buy
125,868
+46,051
+58% +$977K ﹤0.01% 748
2021
Q1 		$2.1M Sell
79,817
-9,459
-11% -$225K ﹤0.01% 765
2020
Q4 		$1.67M Buy
89,276
+39,049
+78% +$729K ﹤0.01% 755
2020
Q3 		$853K Buy
+50,227
New +$976K ﹤0.01% 788

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return

Massachusetts Financial Services's VIVO Position: Q2 2022 in Review

Massachusetts Financial Services sold out of Meridian Bioscience Inc (VIVO) in Q2 2022, closing a stake of 10,238 shares — an estimated $266K sold.

Massachusetts Financial Services first reported a position in VIVO in Q3 2020 and held it in 7 quarters. The position peaked at $2.79M in Q2 2021. 216 funds tracked by Wall St. Rank hold VIVO as of Q2 2022.

  • Massachusetts Financial Services reported no remaining Meridian Bioscience Inc position as of Q2 2022 after selling out during the quarter.
  • Massachusetts Financial Services sold 10,238 Meridian Bioscience Inc shares in Q2 2022, an estimated $266K.
  • Massachusetts Financial Services first reported a position in Meridian Bioscience Inc in Q3 2020 and held it in 7 quarters.
  • Massachusetts Financial Services's Meridian Bioscience Inc position peaked at $2.79M in Q2 2021.
  • 216 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2022.

Based on Massachusetts Financial Services's 13F filing for Q2 2022, filed 9 Aug 2022.